Filing Details

Accession Number:
0001127602-15-012425
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-24 16:12:02
Reporting Period:
2015-03-23
Filing Date:
2015-03-24
Accepted Time:
2015-03-24 16:12:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
64803 Cvs Health Corp CVS Retail-Drug Stores And Proprietary Stores (5912) 050494040
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1351402 A Troyen Brennan One Cvs Drive
Woonsocket RI 02895
Evp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-23 33,274 $45.07 88,360 No 4 M Direct
Common Stock Disposition 2015-03-23 33,274 $104.94 55,086 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2015-03-23 33,274 $0.00 33,274 $45.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
33,274 2013-04-02 2019-04-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock (Restricted) 49,991 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $34.96 2012-04-01 2018-04-01 16,747 16,747 Direct
Common Stock Stock Option $54.53 2014-04-01 2020-04-01 47,207 47,207 Direct
Common Stock Stock Option $74.29 2015-04-01 2021-04-01 54,550 54,550 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2018-04-01 16,747 16,747 Direct
2020-04-01 47,207 47,207 Direct
2021-04-01 54,550 54,550 Direct
Footnotes
  1. All sales were effected pursuant to a Rule 10b5-1 plan.
  2. Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $104.20 and $105.32 per share.
  3. Option became exercisable in four equal annual installments, commencing 4/2/2013.
  4. Option became exercisable in four equal annual installments, commencing 4/1/2012.
  5. Option became exercisable in four equal annual installments, commencing 4/1/2014.
  6. Option becomes exercisable in four equal annual installments, commencing 4/1/2015.